Lung Fibroblast – Passage 2

Lung Fibroblast – Passage 2

Lung Fibroblast – Passage 2

Lung Fibroblast – Passage 2

Intestinal Epithelial Cells Ilium

Lung Fibroblast – Passage 2

Lung Fibroblast – Passage 2

Lung Fibroblast – Passage 2

Lung Fibroblast – Passage 2

25NOVAPOOL™ 10-Donor Mixed-Gender Pooled Human Hepatocytes

NhFL: Normal Human Lung Fibroblast; passage 2

Cells per vial: 500,000

SKU 1501 Categories , ,

Product Shipping & Storage

Upon receipt, immediately transfer each cryovial into the vapor phase of a liquid nitrogen storage tank. Cells are viable for at least 2 years when stored under these conditions.

Quality Control Testing

QC testing results provided will consist of the following:

  • Attachment from P1 thaw: Typically 50-75% of initial count
  • Number of population doublings: Typically 20 (P1 to P3 in your preferred BEGM conditions)
  • Average population doubling time: Typically 40 ± 5 hours (P1 to P2 cells)
  • Transepithelial resistance at 21 days ALI: Typically range from 500 to 2000 Ω (P1 cells starting material, 12mm)
  • Percent ciliated cells at 21 days ALI: Typically >50% of P1 cells

 

  • Donor Characteristics Include: Donor age, sex, race, diabetic status, smoking history, alcohol use, and any co-morbidities
  • Serology results include (positive or negative): CMV, EBV HBV, HCV, HIV-1, HIV-2, potentially HLTV-1 and HLTV-2 ( if performed)
  • Culture results include (positive or negative): Gram +, Gram -, Mycoplasm and Fungi

Product Warranty

CULTURES HAVE A LIMITED LIFESPAN IN VITRO.

Novabiosis guarantees the performance of its cells only if following Novabiosis specific use instructions exclusively, and the recommended protocols are followed. The performance of the cells are not guaranteed if any modifications are made.

Cryopreserved proliferating NhSAE-P1 are assured to be viable and functional when thawed and maintained properly.

THESE PRODUCTS ARE FOR RESEARCH USE ONLY and NOT approved for use in humans or clinical diagnostic testing.

WARNING: Primary human cell products are derived from whole human organs, thus should be treated as potentially infectious. Blood samples from the donor are  tested and found non-reactive using FDA approved test kits in CLIA certified labs and are testing for the presence of HIV-I/II, Hepatitis B Virus and Hepatitis C Virus.  In some cases, but not all, HTLV-1 and 2 are tested and reported.

Test results do not offer complete assurance that HIV-I/II, Hepatitis B Virus, and Hepatitis C Virus are absent. All human sourced products should be handled at the appropriate Biological Safety Level in order to minimize exposure of potentially infectious products.